nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNA6—ganglion—brain cancer	0.0415	0.107	CbGeAlD
Varenicline—CHRNA4—cochlea—brain cancer	0.0375	0.097	CbGeAlD
Varenicline—CHRNA4—telencephalic ventricle—brain cancer	0.0239	0.0619	CbGeAlD
Varenicline—CHRNA6—brainstem—brain cancer	0.018	0.0467	CbGeAlD
Varenicline—CHRNA6—telencephalon—brain cancer	0.016	0.0414	CbGeAlD
Varenicline—CHRNA7—ganglion—brain cancer	0.0151	0.0391	CbGeAlD
Varenicline—CHRNA4—ganglion—brain cancer	0.0149	0.0385	CbGeAlD
Varenicline—CHRNA6—midbrain—brain cancer	0.0115	0.0297	CbGeAlD
Varenicline—CHRNA4—hindbrain—brain cancer	0.0113	0.0292	CbGeAlD
Varenicline—CHRNA6—head—brain cancer	0.00996	0.0258	CbGeAlD
Varenicline—CHRNB2—telencephalon—brain cancer	0.00919	0.0238	CbGeAlD
Varenicline—CHRNA6—central nervous system—brain cancer	0.00909	0.0235	CbGeAlD
Varenicline—CHRNA6—cerebellum—brain cancer	0.00889	0.023	CbGeAlD
Varenicline—CHRNB2—pituitary gland—brain cancer	0.00748	0.0194	CbGeAlD
Varenicline—CHRNB2—medulla oblongata—brain cancer	0.00722	0.0187	CbGeAlD
Varenicline—CHRNA6—brain—brain cancer	0.00722	0.0187	CbGeAlD
Varenicline—CHRFAM7A—telencephalon—brain cancer	0.00721	0.0187	CbGeAlD
Varenicline—CHRNB2—midbrain—brain cancer	0.0066	0.0171	CbGeAlD
Varenicline—CHRNA4—brainstem—brain cancer	0.00647	0.0167	CbGeAlD
Varenicline—CHRNB2—spinal cord—brain cancer	0.00644	0.0167	CbGeAlD
Varenicline—CHRNA7—telencephalon—brain cancer	0.00582	0.0151	CbGeAlD
Varenicline—CHRNA4—telencephalon—brain cancer	0.00574	0.0149	CbGeAlD
Varenicline—CHRNB2—head—brain cancer	0.00572	0.0148	CbGeAlD
Varenicline—CHRNA3—endocrine gland—brain cancer	0.00562	0.0145	CbGeAlD
Varenicline—CHRNA3—head—brain cancer	0.00555	0.0144	CbGeAlD
Varenicline—CHRNB2—central nervous system—brain cancer	0.00522	0.0135	CbGeAlD
Varenicline—CHRNB2—cerebellum—brain cancer	0.0051	0.0132	CbGeAlD
Varenicline—CHRNA3—central nervous system—brain cancer	0.00507	0.0131	CbGeAlD
Varenicline—CHRNA3—cerebellum—brain cancer	0.00495	0.0128	CbGeAlD
Varenicline—CHRFAM7A—endocrine gland—brain cancer	0.00455	0.0118	CbGeAlD
Varenicline—CHRFAM7A—head—brain cancer	0.00449	0.0116	CbGeAlD
Varenicline—CHRNB2—brain—brain cancer	0.00415	0.0107	CbGeAlD
Varenicline—CHRNA4—midbrain—brain cancer	0.00412	0.0107	CbGeAlD
Varenicline—CHRFAM7A—central nervous system—brain cancer	0.0041	0.0106	CbGeAlD
Varenicline—CHRNA4—spinal cord—brain cancer	0.00402	0.0104	CbGeAlD
Varenicline—CHRNA3—brain—brain cancer	0.00402	0.0104	CbGeAlD
Varenicline—CHRNA7—endocrine gland—brain cancer	0.00367	0.0095	CbGeAlD
Varenicline—CHRNA7—head—brain cancer	0.00362	0.00938	CbGeAlD
Varenicline—CHRNA4—endocrine gland—brain cancer	0.00362	0.00937	CbGeAlD
Varenicline—CHRNA4—head—brain cancer	0.00358	0.00926	CbGeAlD
Varenicline—CHRNA7—central nervous system—brain cancer	0.00331	0.00856	CbGeAlD
Varenicline—CHRNA4—central nervous system—brain cancer	0.00326	0.00845	CbGeAlD
Varenicline—CHRFAM7A—brain—brain cancer	0.00325	0.00842	CbGeAlD
Varenicline—CHRNA4—cerebellum—brain cancer	0.00319	0.00826	CbGeAlD
Varenicline—CHRNA7—brain—brain cancer	0.00263	0.0068	CbGeAlD
Varenicline—CHRNA4—brain—brain cancer	0.00259	0.00671	CbGeAlD
Varenicline—Chills—Hydroxyurea—brain cancer	0.00153	0.00249	CcSEcCtD
Varenicline—Tachycardia—Procarbazine—brain cancer	0.00153	0.00249	CcSEcCtD
Varenicline—Photosensitivity reaction—Temozolomide—brain cancer	0.00152	0.00248	CcSEcCtD
Varenicline—Weight increased—Temozolomide—brain cancer	0.00151	0.00247	CcSEcCtD
Varenicline—Hyperhidrosis—Procarbazine—brain cancer	0.00151	0.00247	CcSEcCtD
Varenicline—Hyperglycaemia—Temozolomide—brain cancer	0.0015	0.00245	CcSEcCtD
Varenicline—Stomatitis—Carmustine—brain cancer	0.0015	0.00244	CcSEcCtD
Varenicline—Anorexia—Procarbazine—brain cancer	0.00149	0.00243	CcSEcCtD
Varenicline—Erythema—Hydroxyurea—brain cancer	0.00148	0.00242	CcSEcCtD
Varenicline—Infestation—Temozolomide—brain cancer	0.00148	0.00242	CcSEcCtD
Varenicline—Infestation NOS—Temozolomide—brain cancer	0.00148	0.00242	CcSEcCtD
Varenicline—Depression—Temozolomide—brain cancer	0.00148	0.00241	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00147	0.0024	CcSEcCtD
Varenicline—Nausea—Lomustine—brain cancer	0.00146	0.00239	CcSEcCtD
Varenicline—Hypotension—Procarbazine—brain cancer	0.00146	0.00238	CcSEcCtD
Varenicline—Stomatitis—Temozolomide—brain cancer	0.00145	0.00236	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00143	0.00232	CcSEcCtD
Varenicline—Insomnia—Procarbazine—brain cancer	0.00142	0.00231	CcSEcCtD
Varenicline—Hepatobiliary disease—Temozolomide—brain cancer	0.0014	0.00229	CcSEcCtD
Varenicline—Sinusitis—Temozolomide—brain cancer	0.00139	0.00227	CcSEcCtD
Varenicline—Somnolence—Procarbazine—brain cancer	0.00139	0.00227	CcSEcCtD
Varenicline—Cramp muscle—Etoposide—brain cancer	0.00139	0.00226	CcSEcCtD
Varenicline—Ill-defined disorder—Hydroxyurea—brain cancer	0.00138	0.00224	CcSEcCtD
Varenicline—Anaemia—Hydroxyurea—brain cancer	0.00137	0.00224	CcSEcCtD
Varenicline—Hypoaesthesia—Carmustine—brain cancer	0.00137	0.00224	CcSEcCtD
Varenicline—Hallucination—Carmustine—brain cancer	0.00137	0.00224	CcSEcCtD
Varenicline—Decreased appetite—Procarbazine—brain cancer	0.00136	0.00222	CcSEcCtD
Varenicline—Oedema peripheral—Carmustine—brain cancer	0.00136	0.00221	CcSEcCtD
Varenicline—Connective tissue disorder—Carmustine—brain cancer	0.00135	0.00221	CcSEcCtD
Varenicline—Fatigue—Procarbazine—brain cancer	0.00135	0.0022	CcSEcCtD
Varenicline—Malaise—Hydroxyurea—brain cancer	0.00134	0.00218	CcSEcCtD
Varenicline—Constipation—Procarbazine—brain cancer	0.00134	0.00218	CcSEcCtD
Varenicline—Pain—Procarbazine—brain cancer	0.00134	0.00218	CcSEcCtD
Varenicline—Dysphagia—Etoposide—brain cancer	0.00133	0.00217	CcSEcCtD
Varenicline—Visual impairment—Carmustine—brain cancer	0.00133	0.00216	CcSEcCtD
Varenicline—Hallucination—Temozolomide—brain cancer	0.00133	0.00216	CcSEcCtD
Varenicline—Hypoaesthesia—Temozolomide—brain cancer	0.00133	0.00216	CcSEcCtD
Varenicline—Urinary tract disorder—Temozolomide—brain cancer	0.00132	0.00214	CcSEcCtD
Varenicline—Oedema peripheral—Temozolomide—brain cancer	0.00131	0.00214	CcSEcCtD
Varenicline—Connective tissue disorder—Temozolomide—brain cancer	0.00131	0.00213	CcSEcCtD
Varenicline—Urethral disorder—Temozolomide—brain cancer	0.00131	0.00213	CcSEcCtD
Varenicline—Feeling abnormal—Procarbazine—brain cancer	0.00129	0.0021	CcSEcCtD
Varenicline—Eye disorder—Carmustine—brain cancer	0.00129	0.0021	CcSEcCtD
Varenicline—Convulsion—Hydroxyurea—brain cancer	0.00129	0.0021	CcSEcCtD
Varenicline—Visual impairment—Temozolomide—brain cancer	0.00128	0.00209	CcSEcCtD
Varenicline—Gastrointestinal pain—Procarbazine—brain cancer	0.00128	0.00209	CcSEcCtD
Varenicline—Erythema multiforme—Temozolomide—brain cancer	0.00126	0.00205	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00126	0.00205	CcSEcCtD
Varenicline—Discomfort—Hydroxyurea—brain cancer	0.00125	0.00203	CcSEcCtD
Varenicline—Eye disorder—Temozolomide—brain cancer	0.00124	0.00203	CcSEcCtD
Varenicline—Urticaria—Procarbazine—brain cancer	0.00124	0.00203	CcSEcCtD
Varenicline—Tinnitus—Temozolomide—brain cancer	0.00124	0.00202	CcSEcCtD
Varenicline—Abdominal pain—Procarbazine—brain cancer	0.00124	0.00202	CcSEcCtD
Varenicline—Body temperature increased—Procarbazine—brain cancer	0.00124	0.00202	CcSEcCtD
Varenicline—Cardiac disorder—Temozolomide—brain cancer	0.00124	0.00201	CcSEcCtD
Varenicline—Arrhythmia—Carmustine—brain cancer	0.00123	0.00201	CcSEcCtD
Varenicline—Oedema—Hydroxyurea—brain cancer	0.00121	0.00197	CcSEcCtD
Varenicline—Angiopathy—Temozolomide—brain cancer	0.00121	0.00197	CcSEcCtD
Varenicline—Mental disorder—Carmustine—brain cancer	0.00121	0.00197	CcSEcCtD
Varenicline—Infection—Hydroxyurea—brain cancer	0.0012	0.00196	CcSEcCtD
Varenicline—Immune system disorder—Temozolomide—brain cancer	0.0012	0.00196	CcSEcCtD
Varenicline—Mediastinal disorder—Temozolomide—brain cancer	0.0012	0.00196	CcSEcCtD
Varenicline—Erythema—Carmustine—brain cancer	0.0012	0.00196	CcSEcCtD
Varenicline—Malnutrition—Carmustine—brain cancer	0.0012	0.00196	CcSEcCtD
Varenicline—Chills—Temozolomide—brain cancer	0.0012	0.00195	CcSEcCtD
Varenicline—Nervous system disorder—Hydroxyurea—brain cancer	0.00119	0.00194	CcSEcCtD
Varenicline—Infestation—Etoposide—brain cancer	0.00119	0.00193	CcSEcCtD
Varenicline—Infestation NOS—Etoposide—brain cancer	0.00119	0.00193	CcSEcCtD
Varenicline—Thrombocytopenia—Hydroxyurea—brain cancer	0.00119	0.00193	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00118	0.00192	CcSEcCtD
Varenicline—Skin disorder—Hydroxyurea—brain cancer	0.00118	0.00192	CcSEcCtD
Varenicline—Acute coronary syndrome—Etoposide—brain cancer	0.00117	0.00191	CcSEcCtD
Varenicline—Mental disorder—Temozolomide—brain cancer	0.00117	0.0019	CcSEcCtD
Varenicline—Myocardial infarction—Etoposide—brain cancer	0.00116	0.0019	CcSEcCtD
Varenicline—Back pain—Carmustine—brain cancer	0.00116	0.00189	CcSEcCtD
Varenicline—Erythema—Temozolomide—brain cancer	0.00116	0.00189	CcSEcCtD
Varenicline—Malnutrition—Temozolomide—brain cancer	0.00116	0.00189	CcSEcCtD
Varenicline—Stomatitis—Etoposide—brain cancer	0.00116	0.00189	CcSEcCtD
Varenicline—Anorexia—Hydroxyurea—brain cancer	0.00115	0.00188	CcSEcCtD
Varenicline—Hypersensitivity—Procarbazine—brain cancer	0.00115	0.00188	CcSEcCtD
Varenicline—Dysgeusia—Temozolomide—brain cancer	0.00114	0.00185	CcSEcCtD
Varenicline—Vision blurred—Carmustine—brain cancer	0.00113	0.00184	CcSEcCtD
Varenicline—Tremor—Carmustine—brain cancer	0.00112	0.00183	CcSEcCtD
Varenicline—Asthenia—Procarbazine—brain cancer	0.00112	0.00183	CcSEcCtD
Varenicline—Hepatobiliary disease—Etoposide—brain cancer	0.00112	0.00183	CcSEcCtD
Varenicline—Back pain—Temozolomide—brain cancer	0.00112	0.00183	CcSEcCtD
Varenicline—Anaemia—Carmustine—brain cancer	0.00111	0.00181	CcSEcCtD
Varenicline—Pruritus—Procarbazine—brain cancer	0.00111	0.0018	CcSEcCtD
Varenicline—Agitation—Carmustine—brain cancer	0.0011	0.0018	CcSEcCtD
Varenicline—Vision blurred—Temozolomide—brain cancer	0.00109	0.00178	CcSEcCtD
Varenicline—Tremor—Temozolomide—brain cancer	0.00109	0.00177	CcSEcCtD
Varenicline—Dyspnoea—Hydroxyurea—brain cancer	0.00108	0.00176	CcSEcCtD
Varenicline—Somnolence—Hydroxyurea—brain cancer	0.00108	0.00176	CcSEcCtD
Varenicline—Ill-defined disorder—Temozolomide—brain cancer	0.00108	0.00175	CcSEcCtD
Varenicline—Anaemia—Temozolomide—brain cancer	0.00107	0.00175	CcSEcCtD
Varenicline—Diarrhoea—Procarbazine—brain cancer	0.00107	0.00175	CcSEcCtD
Varenicline—Dyspepsia—Hydroxyurea—brain cancer	0.00107	0.00174	CcSEcCtD
Varenicline—Agitation—Temozolomide—brain cancer	0.00107	0.00174	CcSEcCtD
Varenicline—Hypoaesthesia—Etoposide—brain cancer	0.00106	0.00173	CcSEcCtD
Varenicline—Angioedema—Temozolomide—brain cancer	0.00106	0.00173	CcSEcCtD
Varenicline—Decreased appetite—Hydroxyurea—brain cancer	0.00105	0.00172	CcSEcCtD
Varenicline—Urinary tract disorder—Etoposide—brain cancer	0.00105	0.00172	CcSEcCtD
Varenicline—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00105	0.0017	CcSEcCtD
Varenicline—Malaise—Temozolomide—brain cancer	0.00105	0.0017	CcSEcCtD
Varenicline—Urethral disorder—Etoposide—brain cancer	0.00104	0.0017	CcSEcCtD
Varenicline—Fatigue—Hydroxyurea—brain cancer	0.00104	0.0017	CcSEcCtD
Varenicline—Vertigo—Temozolomide—brain cancer	0.00104	0.0017	CcSEcCtD
Varenicline—Convulsion—Carmustine—brain cancer	0.00104	0.00169	CcSEcCtD
Varenicline—Hypertension—Carmustine—brain cancer	0.00104	0.00169	CcSEcCtD
Varenicline—Constipation—Hydroxyurea—brain cancer	0.00104	0.00169	CcSEcCtD
Varenicline—Pain—Hydroxyurea—brain cancer	0.00104	0.00169	CcSEcCtD
Varenicline—Dizziness—Procarbazine—brain cancer	0.00104	0.00169	CcSEcCtD
Varenicline—Palpitations—Temozolomide—brain cancer	0.00102	0.00167	CcSEcCtD
Varenicline—Myalgia—Carmustine—brain cancer	0.00102	0.00166	CcSEcCtD
Varenicline—Chest pain—Carmustine—brain cancer	0.00102	0.00166	CcSEcCtD
Varenicline—Anxiety—Carmustine—brain cancer	0.00102	0.00166	CcSEcCtD
Varenicline—Cough—Temozolomide—brain cancer	0.00101	0.00165	CcSEcCtD
Varenicline—Erythema multiforme—Etoposide—brain cancer	0.00101	0.00164	CcSEcCtD
Varenicline—Convulsion—Temozolomide—brain cancer	0.001	0.00164	CcSEcCtD
Varenicline—Hypertension—Temozolomide—brain cancer	0.001	0.00163	CcSEcCtD
Varenicline—Feeling abnormal—Hydroxyurea—brain cancer	0.000998	0.00163	CcSEcCtD
Varenicline—Eye disorder—Etoposide—brain cancer	0.000996	0.00162	CcSEcCtD
Varenicline—Vomiting—Procarbazine—brain cancer	0.000995	0.00162	CcSEcCtD
Varenicline—Cardiac disorder—Etoposide—brain cancer	0.000989	0.00161	CcSEcCtD
Varenicline—Myalgia—Temozolomide—brain cancer	0.000987	0.00161	CcSEcCtD
Varenicline—Arthralgia—Temozolomide—brain cancer	0.000987	0.00161	CcSEcCtD
Varenicline—Rash—Procarbazine—brain cancer	0.000987	0.00161	CcSEcCtD
Varenicline—Dermatitis—Procarbazine—brain cancer	0.000986	0.00161	CcSEcCtD
Varenicline—Anxiety—Temozolomide—brain cancer	0.000984	0.0016	CcSEcCtD
Varenicline—Headache—Procarbazine—brain cancer	0.000981	0.0016	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00098	0.0016	CcSEcCtD
Varenicline—Oedema—Carmustine—brain cancer	0.000979	0.0016	CcSEcCtD
Varenicline—Discomfort—Temozolomide—brain cancer	0.000975	0.00159	CcSEcCtD
Varenicline—Infection—Carmustine—brain cancer	0.000973	0.00159	CcSEcCtD
Varenicline—Angiopathy—Etoposide—brain cancer	0.000967	0.00158	CcSEcCtD
Varenicline—Dry mouth—Temozolomide—brain cancer	0.000966	0.00157	CcSEcCtD
Varenicline—Immune system disorder—Etoposide—brain cancer	0.000963	0.00157	CcSEcCtD
Varenicline—Mediastinal disorder—Etoposide—brain cancer	0.000961	0.00157	CcSEcCtD
Varenicline—Thrombocytopenia—Carmustine—brain cancer	0.000959	0.00156	CcSEcCtD
Varenicline—Body temperature increased—Hydroxyurea—brain cancer	0.000958	0.00156	CcSEcCtD
Varenicline—Chills—Etoposide—brain cancer	0.000956	0.00156	CcSEcCtD
Varenicline—Tachycardia—Carmustine—brain cancer	0.000956	0.00156	CcSEcCtD
Varenicline—Oedema—Temozolomide—brain cancer	0.000946	0.00154	CcSEcCtD
Varenicline—Infection—Temozolomide—brain cancer	0.00094	0.00153	CcSEcCtD
Varenicline—Anorexia—Carmustine—brain cancer	0.000933	0.00152	CcSEcCtD
Varenicline—Nausea—Procarbazine—brain cancer	0.00093	0.00152	CcSEcCtD
Varenicline—Nervous system disorder—Temozolomide—brain cancer	0.000928	0.00151	CcSEcCtD
Varenicline—Thrombocytopenia—Temozolomide—brain cancer	0.000927	0.00151	CcSEcCtD
Varenicline—Skin disorder—Temozolomide—brain cancer	0.000919	0.0015	CcSEcCtD
Varenicline—Hypotension—Carmustine—brain cancer	0.000915	0.00149	CcSEcCtD
Varenicline—Hyperhidrosis—Temozolomide—brain cancer	0.000915	0.00149	CcSEcCtD
Varenicline—Dysgeusia—Etoposide—brain cancer	0.000909	0.00148	CcSEcCtD
Varenicline—Anorexia—Temozolomide—brain cancer	0.000902	0.00147	CcSEcCtD
Varenicline—Back pain—Etoposide—brain cancer	0.000898	0.00146	CcSEcCtD
Varenicline—Hypersensitivity—Hydroxyurea—brain cancer	0.000893	0.00145	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Carmustine—brain cancer	0.000892	0.00145	CcSEcCtD
Varenicline—Muscle spasms—Etoposide—brain cancer	0.000892	0.00145	CcSEcCtD
Varenicline—Insomnia—Carmustine—brain cancer	0.000886	0.00144	CcSEcCtD
Varenicline—Dyspnoea—Carmustine—brain cancer	0.000873	0.00142	CcSEcCtD
Varenicline—Somnolence—Carmustine—brain cancer	0.000871	0.00142	CcSEcCtD
Varenicline—Asthenia—Hydroxyurea—brain cancer	0.000869	0.00142	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000862	0.00141	CcSEcCtD
Varenicline—Ill-defined disorder—Etoposide—brain cancer	0.000861	0.0014	CcSEcCtD
Varenicline—Anaemia—Etoposide—brain cancer	0.000858	0.0014	CcSEcCtD
Varenicline—Insomnia—Temozolomide—brain cancer	0.000856	0.00139	CcSEcCtD
Varenicline—Decreased appetite—Carmustine—brain cancer	0.000851	0.00139	CcSEcCtD
Varenicline—Gastrointestinal disorder—Carmustine—brain cancer	0.000845	0.00138	CcSEcCtD
Varenicline—Dyspnoea—Temozolomide—brain cancer	0.000844	0.00137	CcSEcCtD
Varenicline—Somnolence—Temozolomide—brain cancer	0.000841	0.00137	CcSEcCtD
Varenicline—Pain—Carmustine—brain cancer	0.000837	0.00136	CcSEcCtD
Varenicline—Constipation—Carmustine—brain cancer	0.000837	0.00136	CcSEcCtD
Varenicline—Malaise—Etoposide—brain cancer	0.000837	0.00136	CcSEcCtD
Varenicline—Vertigo—Etoposide—brain cancer	0.000834	0.00136	CcSEcCtD
Varenicline—Dyspepsia—Temozolomide—brain cancer	0.000833	0.00136	CcSEcCtD
Varenicline—Diarrhoea—Hydroxyurea—brain cancer	0.000829	0.00135	CcSEcCtD
Varenicline—Decreased appetite—Temozolomide—brain cancer	0.000823	0.00134	CcSEcCtD
Varenicline—Gastrointestinal disorder—Temozolomide—brain cancer	0.000817	0.00133	CcSEcCtD
Varenicline—Fatigue—Temozolomide—brain cancer	0.000816	0.00133	CcSEcCtD
Varenicline—Loss of consciousness—Etoposide—brain cancer	0.000816	0.00133	CcSEcCtD
Varenicline—Cough—Etoposide—brain cancer	0.00081	0.00132	CcSEcCtD
Varenicline—Constipation—Temozolomide—brain cancer	0.000809	0.00132	CcSEcCtD
Varenicline—Pain—Temozolomide—brain cancer	0.000809	0.00132	CcSEcCtD
Varenicline—Feeling abnormal—Carmustine—brain cancer	0.000807	0.00132	CcSEcCtD
Varenicline—Convulsion—Etoposide—brain cancer	0.000804	0.00131	CcSEcCtD
Varenicline—Hypertension—Etoposide—brain cancer	0.000801	0.00131	CcSEcCtD
Varenicline—Dizziness—Hydroxyurea—brain cancer	0.000801	0.00131	CcSEcCtD
Varenicline—Gastrointestinal pain—Carmustine—brain cancer	0.000801	0.00131	CcSEcCtD
Varenicline—Chest pain—Etoposide—brain cancer	0.00079	0.00129	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000785	0.00128	CcSEcCtD
Varenicline—Discomfort—Etoposide—brain cancer	0.000781	0.00127	CcSEcCtD
Varenicline—Feeling abnormal—Temozolomide—brain cancer	0.00078	0.00127	CcSEcCtD
Varenicline—Body temperature increased—Carmustine—brain cancer	0.000774	0.00126	CcSEcCtD
Varenicline—Abdominal pain—Carmustine—brain cancer	0.000774	0.00126	CcSEcCtD
Varenicline—Gastrointestinal pain—Temozolomide—brain cancer	0.000774	0.00126	CcSEcCtD
Varenicline—Vomiting—Hydroxyurea—brain cancer	0.00077	0.00126	CcSEcCtD
Varenicline—Rash—Hydroxyurea—brain cancer	0.000764	0.00124	CcSEcCtD
Varenicline—Dermatitis—Hydroxyurea—brain cancer	0.000763	0.00124	CcSEcCtD
Varenicline—Headache—Hydroxyurea—brain cancer	0.000759	0.00124	CcSEcCtD
Varenicline—Infection—Etoposide—brain cancer	0.000752	0.00123	CcSEcCtD
Varenicline—Urticaria—Temozolomide—brain cancer	0.000752	0.00123	CcSEcCtD
Varenicline—Abdominal pain—Temozolomide—brain cancer	0.000748	0.00122	CcSEcCtD
Varenicline—Body temperature increased—Temozolomide—brain cancer	0.000748	0.00122	CcSEcCtD
Varenicline—Thrombocytopenia—Etoposide—brain cancer	0.000741	0.00121	CcSEcCtD
Varenicline—Tachycardia—Etoposide—brain cancer	0.000739	0.0012	CcSEcCtD
Varenicline—Skin disorder—Etoposide—brain cancer	0.000736	0.0012	CcSEcCtD
Varenicline—Hyperhidrosis—Etoposide—brain cancer	0.000732	0.00119	CcSEcCtD
Varenicline—Anorexia—Etoposide—brain cancer	0.000722	0.00118	CcSEcCtD
Varenicline—Hypersensitivity—Carmustine—brain cancer	0.000722	0.00118	CcSEcCtD
Varenicline—Nausea—Hydroxyurea—brain cancer	0.00072	0.00117	CcSEcCtD
Varenicline—Hypotension—Etoposide—brain cancer	0.000708	0.00115	CcSEcCtD
Varenicline—Asthenia—Carmustine—brain cancer	0.000703	0.00115	CcSEcCtD
Varenicline—Hypersensitivity—Temozolomide—brain cancer	0.000697	0.00114	CcSEcCtD
Varenicline—Asthenia—Temozolomide—brain cancer	0.000679	0.00111	CcSEcCtD
Varenicline—Dyspnoea—Etoposide—brain cancer	0.000675	0.0011	CcSEcCtD
Varenicline—Somnolence—Etoposide—brain cancer	0.000673	0.0011	CcSEcCtD
Varenicline—Diarrhoea—Carmustine—brain cancer	0.00067	0.00109	CcSEcCtD
Varenicline—Pruritus—Temozolomide—brain cancer	0.00067	0.00109	CcSEcCtD
Varenicline—Decreased appetite—Etoposide—brain cancer	0.000658	0.00107	CcSEcCtD
Varenicline—Gastrointestinal disorder—Etoposide—brain cancer	0.000654	0.00107	CcSEcCtD
Varenicline—Fatigue—Etoposide—brain cancer	0.000653	0.00106	CcSEcCtD
Varenicline—Dizziness—Carmustine—brain cancer	0.000648	0.00106	CcSEcCtD
Varenicline—Pain—Etoposide—brain cancer	0.000648	0.00106	CcSEcCtD
Varenicline—Constipation—Etoposide—brain cancer	0.000648	0.00106	CcSEcCtD
Varenicline—Diarrhoea—Temozolomide—brain cancer	0.000648	0.00106	CcSEcCtD
Varenicline—Dizziness—Temozolomide—brain cancer	0.000626	0.00102	CcSEcCtD
Varenicline—Feeling abnormal—Etoposide—brain cancer	0.000624	0.00102	CcSEcCtD
Varenicline—Vomiting—Carmustine—brain cancer	0.000623	0.00101	CcSEcCtD
Varenicline—Gastrointestinal pain—Etoposide—brain cancer	0.000619	0.00101	CcSEcCtD
Varenicline—Rash—Carmustine—brain cancer	0.000617	0.00101	CcSEcCtD
Varenicline—Dermatitis—Carmustine—brain cancer	0.000617	0.00101	CcSEcCtD
Varenicline—Headache—Carmustine—brain cancer	0.000614	0.001	CcSEcCtD
Varenicline—Vomiting—Temozolomide—brain cancer	0.000602	0.000981	CcSEcCtD
Varenicline—Urticaria—Etoposide—brain cancer	0.000602	0.00098	CcSEcCtD
Varenicline—Abdominal pain—Etoposide—brain cancer	0.000599	0.000976	CcSEcCtD
Varenicline—Body temperature increased—Etoposide—brain cancer	0.000599	0.000976	CcSEcCtD
Varenicline—Rash—Temozolomide—brain cancer	0.000597	0.000972	CcSEcCtD
Varenicline—Dermatitis—Temozolomide—brain cancer	0.000596	0.000972	CcSEcCtD
Varenicline—Headache—Temozolomide—brain cancer	0.000593	0.000966	CcSEcCtD
Varenicline—Nausea—Carmustine—brain cancer	0.000582	0.000948	CcSEcCtD
Varenicline—Nausea—Temozolomide—brain cancer	0.000562	0.000916	CcSEcCtD
Varenicline—Hypersensitivity—Etoposide—brain cancer	0.000558	0.000909	CcSEcCtD
Varenicline—Asthenia—Etoposide—brain cancer	0.000543	0.000885	CcSEcCtD
Varenicline—Pruritus—Etoposide—brain cancer	0.000536	0.000873	CcSEcCtD
Varenicline—Diarrhoea—Etoposide—brain cancer	0.000518	0.000844	CcSEcCtD
Varenicline—Dizziness—Etoposide—brain cancer	0.000501	0.000816	CcSEcCtD
Varenicline—Vomiting—Etoposide—brain cancer	0.000482	0.000785	CcSEcCtD
Varenicline—Rash—Etoposide—brain cancer	0.000477	0.000778	CcSEcCtD
Varenicline—Dermatitis—Etoposide—brain cancer	0.000477	0.000777	CcSEcCtD
Varenicline—Headache—Etoposide—brain cancer	0.000474	0.000773	CcSEcCtD
Varenicline—Nausea—Etoposide—brain cancer	0.00045	0.000733	CcSEcCtD
